Advertisement
Screener

INNOVATION1 BIOTECH INC. Interest Expense, Debt, Excluding Amortization

INNOVATION1 BIOTECH INC. Interest Expense, Debt, Excluding Amortization

INNOVATION1 BIOTECH INC. reported Interest Expense, Debt, Excluding Amortization of $132.80 thousand for the 6-month period ending 2024-02-29, per its 10-Q filed 2025-05-06.

Financial Statements › Expense Statement › Interest Expense

us-gaap:InterestExpenseDebtExcludingAmortization · last filed 2025-05-06

  • INNOVATION1 BIOTECH INC. interest expense, debt, excluding amortization for the quarter ending 2024-02-29 was $119.14K, a 166.89% increase year-over-year.
  • INNOVATION1 BIOTECH INC. interest expense, debt, excluding amortization for the quarter ending 2023-11-30 was $13.66K, a 402.10% increase year-over-year.
  • INNOVATION1 BIOTECH INC. interest expense, debt, excluding amortization for the quarter ending 2023-08-31 was $247.36K.
  • INNOVATION1 BIOTECH INC. interest expense, debt, excluding amortization for the quarter ending 2023-05-31 was $90.46K.
  • INNOVATION1 BIOTECH INC. interest expense, debt, excluding amortization for fiscal 2023 was $385.18K.
Period endInterest Expense, Debt, Excluding Amortization 3 monthInterest Expense, Debt, Excluding Amortization 6 monthInterest Expense, Debt, Excluding Amortization 9 monthInterest Expense, Debt, Excluding Amortization 12 month
2024-02-29$119.14K
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-05-06
$132.80K
10-Q · filed 2025-05-06
$380.16K
derived: sum of 3 quarters · filed 2025-05-06
$470.62K
derived: sum of 4 quarters · filed 2025-05-06
2023-11-30$13.66K
10-Q · filed 2025-01-27
$261.02K
derived: sum of 2 quarters · filed 2025-01-27
$351.48K
derived: sum of 3 quarters · filed 2025-01-27
$396.12K
derived: sum of 4 quarters · filed 2025-01-27
2023-08-31$247.36K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-01-17
$337.82K
derived: sum of 2 quarters · filed 2024-01-17
$382.46K
derived: sum of 3 quarters · filed 2024-01-17
$385.18K
10-K · filed 2024-01-17
2023-05-31$90.46K
10-Q · filed 2023-09-13
$135.10K
derived: sum of 2 quarters · filed 2023-09-13
$137.82K
10-Q · filed 2023-09-13
2023-02-28$44.64K
10-Q · filed 2023-05-30
$47.36K
10-Q · filed 2023-05-30
2022-11-30$2.72K
10-Q · filed 2023-01-17